{"id":"W4413836422","doi":"10.1158/1078-0432.ccr-24-4342","title":"Phase I Dose-Escalation Trial Combining Olaparib and Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca; AstraZeneca United States","keywords":"Medicine; Olaparib; Pneumonitis; Esophagitis; Internal medicine; PARP inhibitor; Radiation therapy; Adverse effect; Oncology; Gastroenterology; Urology; Surgery; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001374994,0.001352066,0.001778232,0.0003949689,0.0003802218,0.0009878164,0.001052717,0.001015086,0.002796238],"category_scores_gemma":[0.0008722699,0.0005546823,0.001031054,0.0004382974,0.001057454,0.000737398,0.0003949597,0.003725622,0.0005243579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009022782,"about_ca_system_score_gemma":0.001517517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005262937,"about_ca_topic_score_gemma":0.001628956,"domain_scores_codex":[0.9995734,0.0001935051,0.00003017064,0.00008513481,0.00004084836,0.00007689471],"domain_scores_gemma":[0.9990251,0.0001612148,0.000229677,0.00009834408,0.00004679755,0.0004388438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7716689,0.1073762,0.006042358,0.0006763305,0.0009983798,0.0002331569,0.0002472554,0.004357439,0.04104917,0.0001922627,0.002091159,0.0650674],"study_design_scores_gemma":[0.5774199,0.4084127,0.006799274,0.00002445211,0.0002656127,0.0002054383,0.00003610128,0.001668948,0.003856026,0.0001588337,0.001128837,0.00002388772],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959531,0.0007699714,0.0003149171,0.0001875286,0.00007399282,0.001654135,0.0002770179,0.00006347413,0.0007058516],"genre_scores_gemma":[0.9942487,0.0005421002,0.001080838,0.0003656009,0.0001036354,0.001802418,0.0007849129,0.00001426349,0.001057512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002796238,"threshold_uncertainty_score":0.009354353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2474000908450765,"score_gpt":0.6157291510270154,"score_spread":0.3683290601819389,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}